On these grounds, the present study aimed at exploring the possible correlation of KIR/HLA haplotypes with the induction of a pCR after NC in a cohort of patients affected by locally advanced BC overexpressing HER2 and treated with trastuzumab. This evidence concerns the gene ERBB2 and breast cancer.